Rachel Humphrey, M.D.
Board Member
Pyxis Oncology, Inc. (PYXS)Equibles does not estimate personal net worth.
Get an email with a short summary when Pyxis Oncology, Inc. publishes a filing, an earnings call transcript or a press release.
Get PYXS alertsAbout Rachel Humphrey, M.D.
Rachel Humphrey, M.D. is recorded as Board Member at Pyxis Oncology, Inc. (PYXS) since August 11, 2022. Pyxis Oncology, Inc. reported in an 8-K filed August 15, 2022 that Rachel Humphrey, M.D. was appointed Board of Directors, effective August 11, 2022. Pyxis Oncology, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Pyxis Oncology, Inc. includes Thomas Civik (CEO, Chairman and Board Member), Pamela Connealy (COO), Jitendra Wadhane (Chief Accounting Officer) and 3 others.
“On August 11, 2022, Pyxis Oncology, Inc. appointed Rachel Humphrey, M.D., to its Board of Directors and to serve on the Board's Nominating and Corporate Governance Committee and Compensation Committee.”
Affiliation history
-
Current
2022-08-11–present
Company network
Leadership on record at Pyxis Oncology, Inc.
- Thomas Civik CEO, Chairman, Board Member
- Pamela Connealy COO
- Jitendra Wadhane Chief Accounting Officer
- Jakob Dupont, M.D. Board Member
- Michael A. Metzger Board Member
- Santhosh Palani, Ph.D., CFA Board Member